Bio Innovation Conference | Agenda at a Glance
Presented by Maryland Life Sciences, a division of the Maryland Tech Council, the Bio Innovation Conference is driving the future of life sciences in Maryland. This conference provides a forum for professionals from industry, academia and government to discuss trends and insight into Maryland’s burgeoning life sciences industry and topics related to funding, structuring, commercialization and government relations.
Maryland Life Sciences Bio Innovation Conference, Bio Innovation Conference, Maryland, life sciences, biotechnology, Maryland Tech Council, bio, innovation, conference, Maryland Life Sciences, Bio Innovation Conference, vaccines, gene therapy, networking, Washington DC, DMV, Biohealth, biohealth capital region, sciences, entrepreneurship, entrepreneur, startup, Maryland Life Sciences Bio Innovation Conference, Maryland Tech Council Conference, annual conference
20103
page-template-default,page,page-id-20103,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive
 

Agenda at a Glance

Draft Agenda (Updated 08-02-2021)

Day 1  |  October 4, 2021

 

7:00 am – 7:00 pm BIO One-on-One Partnering Open
7:00 am – 8:00 pm Registration Open – Breakfast and Networking
8:00 am – 8:45 am Welcome and Opening Remarks

  • Martin Rosendale, Chief Executive Officer, Maryland Tech Council
8:45 am – 9:45 am Keynote Speaker

  • Gary L. Disbrow, Ph.D., Director, Deputy Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority
    U.S. Department of Health and Human Services (confirmed)
9:45 am – 10:00 am Break
10:00 am – 10:50 am Keynote Speaker

  • Richard Hatchett, Chief Executive Officer, Coalition for Epidemic Preparedness Innovations (invited)
11:00  am – 11:50  am Disruptive Technology Innovation and Vaccine Development

  • Bill Enright, Chief Executive Officer, Vaccitech (invited)
  • Pfizer Representative (invited)
  • Novavax Representative (invited)
  • GSK Representative (invited)
12:00 pm – 1:00 pm Networking Lunch
1:00 pm – 1:50 pm Health Equity and Vaccine Confidence

  • Stephen B. Thomas, Professor, Health Policy and Management, Director, Center for Health Equity, University of Maryland (confirmed)
  • Dr. Lisa Dunkle, Vice President, Global Medical Lead for Coronavirus vaccine, Novavax (confirmed)
  • Matthew Hepburn, Director, COVID Vaccine Development, HHS-DoD
  • White House Health Equity
2:00 pm – 2:50 pm Innovation in Clinical Trials
3:00 pm – 3:50 pm Life Sciences Workforce Trends

Moderator

  • Ulyana V. Desiderio, PhD, Director, BioHealth and Life Sciences, Department of Commerce (invited)

Speakers:

  • Joe Sanchez, PhD, MBA, Director, R&D Science Engagement at AstraZeneca (invited)
  • Brian Stamper, Senior Director of Manufacturing at Kite (invited)
4:00 pm – 5:30 pm Cocktail Reception

Day 2  |  October 5, 2021

7:00 am – 7:00 pm BIO One-on-One Partnering Open
7:00 am – 8:00 am Registration Open – Breakfast and Networking
8:00 am – 9:00 am Welcome and Keynote Speaker

Welcome

  • Martin Rosendale, Chief Executive Officer, Maryland Tech Council

Keynote Speaker

  • Dr. David Agus, CBS News medical contributor, American Physician and Author
9:00 am – 9:50 am Engineered Cell Therapies: Increasingly Complex Product Development

Welcome

  • Doug Doerfler, Chief Executive Officer, MaxCyte

Moderator

  • Sarah Meeks, Vice President, Business Development, MaxCyte

Speakers:

  • Mike Klichinsky, Co-Founder Senior Vice President, Research, Carisma Therapeutics (confirmed)
  • Mike Singer, Chief Scientific Officer, Cartesian Therapeutics (confirmed)
10:00  am – 10:50  am Cell and Gene Therapy: CMC and Manufacturing Hurdles and Solutions

Moderator

  • Jeffrey Hung, General Manager, Vigene Biosciences

Speakers:

  • Chris McDonald, Global Head of Manufacturing, Kite Pharma, a Gilead Company (confirmed)
  • Jon Rowley, Founder and Chief Scientific Officer, Rooster Bio (confirmed)
  • Daniel Smith, Professor, University of Kent and Executive Director, Charles River Labs (confirmed)
11:00 am – 11:50 am Cell and Gene Therapy: Beyond Oncology

Moderator

  • Murat Kalayoglu, MD, PhD. President & Chief Executive Officer, Cartesian Therapeutics

Speakers:

  • Suk See DeRavin, Clinician, National Institutes of Allergy and Infectious Diseases (confirmed)
  • Dr. Bruce Levy, Chief of Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Harvard Medical School (confirmed)
  • Dr. Tahseen Mozaffar, Professor, Interim Chair of Neurology, University of California, Irvine (confirmed)
12:00 pm – 1:00 pm Lunch Break
1:00 pm – 1:50 pm Biomanufacturing: Buy it or Build it (Pros and cons of insourcing vs. outsourcing)

Moderator:

  • CRB Group Represenative

Speakers:

  • Jim Jackson, Vice President, Manufacturing, Kite Pharma (invited)
  • Craig Malzahn, Vice President, Technical Operations, RegenxBio (confirmed)
  • Thomas VanCott, Ph.D, Global Head of Product Development, Cell and Gene Therapy, Catalent Biologics (invited)
2:00 pm – 2:50 pm Revolution in Biomanufacturing

Moderator

  • Martin Rosendale, Chief Executive Officer, Maryland Tech Council

Speakers:

  • Nicholas Ostrout, PhD, Director (Head) of Commercial Development – Personalized Medicine, Lonza (confirmed)
  • Emergent Represenative – (Invited)
3:00 pm – 3:50 pm Biomanufacturing: Risk, Quality and Cost

Moderator

  • Andy York, Executive Director, Maryland Prescription Drug Affordability Board (confirmed)